KLRS
Kalaris Therapeutics
KLRS
KLRS
71 hedge funds and large institutions have $854M invested in Kalaris Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 61 → 71 (+10)
0.17% more ownership
Funds ownership: 1.4% → 1.56% (+0.17%)
Holders
71
Holding in Top 10
–
Calls
$19K
Puts
$7K
Top Buyers
| 1 | +$24.7M | |
| 2 | +$20.7M | |
| 3 | +$19.4M | |
| 4 |
TG
TCW Group
Los Angeles,
California
|
+$8.31M |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
+$4.52M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$9.85M | |
| 3 | -$5.81M | |
| 4 |
Goldman Sachs
New York
|
-$1.24M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$1.07M |